SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Myriad Genetics Inc. (MYGN) on Monday reported a loss of $61.3 million in its third quarter. The Salt Lake City-based company said it had a loss of 75 cents per share. Losses, adjusted for non-recurring costs and stock option expense,…Read More
Myriad Q3 Earnings Snapshot
